IRCT201202128660N1CompletedPhase 2
The study of adjunctive Progesterone therapy effectiveness in intractable catamenial epilepsy
Research Department, Medical school, Isfahan University of Medical Sciences0 sites38 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 38
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 40 years (—)
- Sex
- Female
Inclusion Criteria
- •1- The women between 18 and 45 years of age who had clinically and electrographically documented refractory CPS or SGMS of temporal lobe origin; 2- All the women with demonstrated catamenial pattern of seizure exacerbation premenstrually between days 25 and 2 or during the entire luteal phase of the menstrual cycle between days 2 and 10; 3- The women with seizure exacerbation during the entire luteal phase with inadequate luteal phase cycles as documented by low serum progesterone levels less than 5 ng/ml during the mid-luteal phase; 5- The women who had premenstrual exacerbations with normal mid-luteal phase progesterone levels; 6- No pregnant and not lactating women who had no amenorrhea or had taken no major tranquilizers, antidepressant medications or OCP during 3 month prior to participate. Exclusion criteria: 1- Immigration; 2- Inaccessibility; 3- Giving up the participation; 4- Sever progesterone complications.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
Evaluation of treatment with progesterone in controlled ovarian stimulation for patients undergoing IVF/ICSI cycles to prevent ovulation: a randomized clinical trialInfertilityJPRN-UMIN000035469Hanabusa Womens' clinic50
Completed
Phase 2
Progesterone effect on threatened abortioabortion.Fetus and newborn affected by other maternal complications of pregnancy Spontaneous abortion, fetusIRCT201012035294N1Vice chancellor for research,Tehran University of Medical Sciences100
Completed
Not Applicable
Effects of progesterone on uterine vascular flow in pregnant womePreterm labor and IUGR Fetus.Slow fetal growth, unspecifiedIRCT201203289338N1Tehran University of Medical Sciences100
Completed
Not Applicable
Effect of progesterone administration on outcome of patients with diffuse axonal injury due to severe head traumadiffuse axonal injury.Diffuse brain injuryIRCT201011225230N1Vice chancellor for research, Tabriz University of Medical Sciences76
Active, not recruiting
Phase 1
The Effect of Vaginal Progesterone Administration in the prevention of Preterm Birth in Women with Short Cervix, [also Known as: Vaginal progesterone bioadhesive gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix-Trial (PREGNANT Short Cervix-Trial)] - PREGNANT Short Cervix-TrialPreterm birth (less than or equal to 32 6/7 weeks gestation)EUCTR2008-007498-19-CZColumbia Laboratories, Inc450